Thinking about trading options or stock in Microsoft, Novo Nordisk, Palantir Technologies, Netflix, or Exxon Mobil?

Zynerba Pharmaceuticals Inc

Change company Symbol lookup

Select an option...

ZYNE Zynerba Pharmaceuticals Inc

PDO PIMCO Dynamic Income Opportunities Fund

BOCT Innovator U.S. Equity Buffer ETF™ October

BAC Bank of America Corp

YARIY Yara International ASA

XOM Exxon Mobil Corp

XLF Financial Select Sector SPDR® Fund

XFLT XAI Octagon Floating Rate & Alternative Income Term Trust

WPC WP Carey Inc

WMT WALMART STORES INC

Health Care : Pharmaceuticals | Small Cap Value

Company profile

Zynerba Pharmaceuticals, Inc. is a biopharmaceutical company engaged in the pharmaceutically-produced transdermal cannabinoid therapies for orphan neuropsychiatric disorders. The Company is engaged in improving the lives of patients and their families living with severe, chronic health conditions, including Fragile X syndrome (FXS), and chromosome 22q11.2 deletion syndrome (22q). It is focused on using cannabinoids for treating behavioral symptoms of FXS and 22q. It is developing Zygel (ZYN002), a pharmaceutically produced cannabidiol formulated as a permeation-enhanced gel for transdermal delivery and manufactured without the presence of tetrahydrocannabinol (THC). It uses a patent protected formulation containing ethanol and propylene glycol as solubilizing agents and Transcutol HP as a permeation enhancer. Zygel is an investigational drug product in development for the potential treatment of behavioral symptoms associated with FXS, 22q, and autism spectrum disorder (ASD).

Thinking about trading options or stock in Microsoft, Novo Nordisk, Palantir Technologies, Netflix, or Exxon Mobil?

9:31 am ET September 14, 2023 (PR Newswire) Print

InvestorsObserver issues critical PriceWatch Alerts for MSFT, NVO, PLTR, NFLX, and XOM.

https://mma.prnewswire.com/media/1333368/InvestorsObserver_Logo.jpg

Click a link below then choose between in-depth options trade idea report or a stock score report.

Options Report - Ideal trade ideas on up to seven different options trading strategies. The report shows all vital aspects of each option trade idea for each stock.

Stock Report - Measures a stock's suitability for investment with a proprietary scoring system combining short and long-term technical factors with Wall Street's opinion including a 12-month price forecast.

-- MSFT: https://www.investorsobserver.com/lp/pr-options-lp-2/?stocksymbol=MSFT&prnumber=091420231

-- NVO: https://www.investorsobserver.com/lp/pr-options-lp-2/?stocksymbol=NVO&prnumber=091420231

-- PLTR: https://www.investorsobserver.com/lp/pr-options-lp-2/?stocksymbol=PLTR&prnumber=091420231

-- NFLX: https://www.investorsobserver.com/lp/pr-options-lp-2/?stocksymbol=NFLX&prnumber=091420231

-- XOM: https://www.investorsobserver.com/lp/pr-options-lp-2/?stocksymbol=XOM&prnumber=091420231

(Note: You may have to copy this link into your browser then press the [ENTER] key.)

InvestorsObserver provides patented technology to some of the biggest names on Wall Street and creates world-class investing tools for the self-directed investor on Main Street. We have a wide range of tools to help investors make smarter decisions when investing in stocks or options.

https://c212.net/c/img/favicon.png?sn=CG10063&sd=2023-09-14

View original content to download multimedia:https://www.prnewswire.com/news-releases/thinking-about-trading-options-or-stock-in-microsoft-novo-nordisk-palantir-technologies-netflix-or-exxon-mobil-301927777.html

SOURCE InvestorsObserver

https://rt.newswire.ca/rt.gif?NewsItemId=CG10063&Transmission_Id=202309140931PR_NEWS_USPR_____CG10063&DateId=20230914

COMTEX_440200358/1005/2023-09-14T09:31:28